Atlas Trials

Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection

Clinical trial NCT01534546 · UNKNOWN

Trial details

NCT number
NCT01534546
Sponsor
Peking University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Gastric Carcinoma
Start date
2012-03-01
Primary completion
2019-07-01
Enrollment
1094

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.